Gallium-67-citrate scintiscans was performed in 149 cases with a variety of malignant,
benign, and inflammatory lesions. Gallium-67-citrate was noted to be valuable in the …

Since its introduction in 1969, 67 Ga has become the most widely employed tumorscanning
agent in nuclear medicine. While 67 Ga is far from being the ideal tumor-scanning agent, it …

A brief review has been made of the uses of radioisotopes of gallium and recent reports of
tumour scanning with 67Ga citrate. In our own work 25 patients have been scanned 48–72 …

Gallium scan detection of various neoplasms is tabulated by anatomic and histologic
categories. The experience with many neoplasms is sufficient to accurately predict the …

To provide data for radiation dosimetry of 67Ga, recently introduced for scanning tumors, we
have tabulated the tissue distribution of 23 autopsies after intravenous administration …

Scintiscanning with/sup 67/Ga-citrate was performed in 162 patients with various pulmonary
diseases. Of the 70 cases of primary pulmonary carcinoma, 62 had a strongly positive and 7 …

FIG. 2. Case2.(Left) Posteriorphotoscanof uppertorsomad. on ORAU whole-body scanner 19
hr after administration of 2.5 mCi of †VGacitrate. No contrast enhancement was …

Gallium-67 citrate administered intravenously is localised in a variety of malignant tumours
and can be detected by scintiscanning. Twenty patients with a variety of malignant …

Difficulties in scanning are encountered with 47Ca because of the high energy of its
principal gamma ray (1.3 MeV). Strontium-85 has a lower gamma-ray energy (0.51 MeV) but …

In spite of localization of gallium in the lungs in a large variety of inflammatory pulmonary
diseases, the chest radiograph is and will continue to be the principal diagnostic tool for …